BALANCE SHEET
Marksans Pharma Ltd.
BSE
Jun 04
256.95
-3.85 ( -1.48%)
Volume
31835
Prev. Close
260.80
Open Price
262.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jun 04
256.80
-4.55 ( -1.74%)
Volume
749092
Prev. Close
261.35
Open Price
262.00
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Balance Sheet
for the last 5 years.
|
ISIN No
|
INE750C01026
|
Market Cap. ( ₹ in Cr. )
|
11637.24
|
P/BV
|
5.10
|
Book Value ( ₹ )
|
50.34
|
|
BSE Code
|
524404
|
52 Week High/Low ( ₹ )
|
359/130
|
FV/ML
|
1/1
|
P/E(X)
|
30.58
|
|
NSE Code
|
MARKSANSEQ
|
Book Closure
|
17/09/2024
|
EPS ( ₹ )
|
8.40
|
Div Yield (%)
|
0.31
|
(₹ in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| No. of Equity Shares (in Lacs) | 4531.60 | 4531.64 | 4531.64 | 4093.14 | 4093.14 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 |
| Total Share Capital | 45.32 | 45.32 | 45.32 | 40.93 | 40.93 |
| | | | | | |
| Reserves and Surplus | 1338.17 | 1177.39 | 1066.01 | 743.74 | 558.79 |
| Total Reserves and Surplus | 1338.17 | 1177.39 | 1066.01 | 743.74 | 558.79 |
| Total Shareholders Funds | 1383.49 | 1222.71 | 1111.32 | 784.67 | 599.72 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Deferred Tax Liabilities [Net] | 12.15 | 9.41 | 8.64 | 9.01 | 8.49 |
| Other Long Term Liabilities | 8.26 | 7.02 | 5.18 | 3.55 | 13.34 |
| Long Term Provisions | 5.77 | 4.47 | 3.18 | 1.86 | 2.11 |
| Total Non-Current Liabilities | 26.18 | 20.90 | 17.00 | 14.41 | 23.94 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 0.00 | 0.00 | 0.00 | 5.00 | 0.00 |
| Trade Payables | 203.53 | 159.72 | 111.58 | 74.45 | 64.15 |
| Other Current Liabilities | 140.65 | 110.77 | 103.64 | 86.35 | 29.78 |
| Short Term Provisions | 1.45 | 1.96 | 1.33 | 0.72 | 0.97 |
| Total Current Liabilities | 345.64 | 272.44 | 216.54 | 166.53 | 94.90 |
| | | | | | |
| Total Capital And Liabilities | 1755.30 | 1516.04 | 1344.86 | 965.61 | 718.55 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 353.59 | 268.51 | 140.88 | 131.86 | 124.84 |
| Intangible Assets | 29.78 | 3.07 | 3.06 | 3.65 | 4.24 |
| Capital Work-In-Progress | 0.00 | 0.00 | 3.91 | 0.00 | 0.00 |
| Fixed Assets | 383.37 | 271.58 | 147.85 | 135.51 | 129.09 |
| Non-Current Investments | 265.75 | 265.75 | 265.75 | 236.07 | 236.07 |
| Deferred Tax Assets [Net] | 1.11 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Assets | 22.84 | 31.01 | 17.50 | 4.16 | 4.16 |
| Total Non-Current Assets | 673.08 | 568.33 | 431.10 | 375.75 | 369.32 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 0.74 | 26.99 | 0.54 | 0.44 | 0.00 |
| Inventories | 205.21 | 190.85 | 130.95 | 103.68 | 93.69 |
| Trade Receivables | 549.58 | 370.17 | 305.49 | 246.78 | 146.79 |
| Cash And Cash Equivalents | 268.69 | 312.23 | 440.26 | 224.05 | 105.71 |
| OtherCurrentAssets | 58.00 | 47.46 | 36.52 | 14.92 | 3.05 |
| Total Current Assets | 1082.22 | 947.70 | 913.76 | 589.86 | 349.24 |
| | | | | | |
| Total Assets | 1755.30 | 1516.04 | 1344.86 | 965.61 | 718.55 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 0.00 | 22.06 | 9.31 | 114.36 | 115.10 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 0.00 | 265.75 | 265.75 | 236.07 | 236.07 |
| | | | | | |
| CURRENT INVESTMENTS | | | | | |
| Current Investments Unquoted Book Value | 0.00 | 26.99 | 0.00 | 0.00 | 0.00 |